Stereotactic radiofrequency ablation as a valid first-line treatment option for hepatocellular adenomas

Stereotactic radiofrequency ablation as a valid first-line treatment option for hepatocellular adenomas

Objectives This study aimed to assess the safety and efficacy of stereotactic radiofrequency ablation (SRFA) in patients with hepatocellular adenomas (HCA).Methods Retrospective analyses of all patients referred for SRFA treatment at our institution between January 2010 and October 2020 revealed 14...

Full description

Bibliographic Details
Main Authors: Gregor Laimer, Peter Schullian, Yannick Scharll, Daniel Putzer, Gernot Eberle, Georg Oberhuber, Reto Bale
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:International Journal of Hyperthermia
Subjects:
Radiofrequency ablation
liver neoplasms
tomography
X-ray computed
treatment outcome
Online Access:https://www.tandfonline.com/doi/10.1080/02656736.2022.2082562

Similar Items

Similar Items